User: Guest  Login
Document type:
Journal Article 
Author(s):
Haas, S 
Title:
Rivaroxaban -- an oral, direct Factor Xa inhibitor: lessons from a broad clinical study programme. 
Abstract:
Anticoagulants are recommended for the prevention and treatment of venous thromboembolism (VTE), prevention of stroke in patients with atrial fibrillation (AF) and secondary prevention in patients with acute coronary syndrome (ACS). There is a clinical need for novel anticoagulants offering improvements over current standard of care, such as fixed oral dosing and no need for routine monitoring. Rivaroxaban, an oral, once-daily, direct Factor Xa inhibitor, has recently completed the RECORD phase...    »
 
Journal title abbreviation:
Eur J Haematol 
Year:
2009 
Journal volume:
82 
Journal issue:
Pages contribution:
339-49 
Language:
eng 
Print-ISSN:
0902-4441 
TUM Institution:
Institut für Experimentelle Onkologie und Therapieforschung 
versions